1025 Tumor-specific CD8+ T cells epigenetically licensed by IL-7R are critical for anti-tumor immunity in melanoma

• Harriet Kluger,
• Nikhil Joshi,
• Marcus Bosenberg,
• Lilach Aizenbud,
• Noah Hornick,
• Esen Sefik,
• Goran Micevic,
• Andrew Daniels,
• Karine Flem-Karlsen,
• Koonam Park,
• Ronan Talty,
• Meaghan McGeary,
• Haris Mirza,
• Holly N Blackburn,
• Julie F Cheung,
• Akiko Iwasaki,
• Richard Flavell

Affiliations

Harriet Kluger

4Yale Cancer Center, New Haven, CT, USA

Nikhil Joshi

1Bristol Heart Institute

Marcus Bosenberg

1Yale University, New Haven, CT, USA

Lilach Aizenbud

Department of Internal Medicine (Medical Oncology), Yale School of Medicine, New Haven, Connecticut, USA

Noah Hornick

Yale School of Medicine, New Haven, CT, United States

Esen Sefik

Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, USA

Goran Micevic

1Yale University, New Haven, CT, USA

Andrew Daniels

1Yale University, New Haven, CT, USA

Karine Flem-Karlsen

1Yale University, New Haven, CT, USA

Koonam Park

1Yale University, New Haven, CT, USA

Ronan Talty

1Yale University, New Haven, CT, USA

Meaghan McGeary

1Yale University, New Haven, CT, USA

Haris Mirza

1Yale University, New Haven, CT, USA

Holly N Blackburn

1Yale University, New Haven, CT, USA

Julie F Cheung

1Yale University, New Haven, CT, USA

Akiko Iwasaki

1Yale University, New Haven, CT, USA

Richard Flavell

1Yale University, New Haven, CT, USA